Randomized Trialvery high evidence
Retatrutide Once Weekly in Adults with Knee Osteoarthritis Pain and Obesity.
The New England journal of medicine·November 8, 2026·PMID 43001755
Why it mattersPainful knee osteoarthritis in patients with obesity is challenging to manage; weight loss can improve symptoms but is difficult to sustain. Retatrutide offers a novel pharmacologic approach that simultaneously addresses obesity and pain, potentially reducing the need for analgesics or joint interventions.

The papers that matter, first.
MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.
§
MedLit · Evidence, Distilled